Ouraring v. RingConn: ITC Smart Ring Patent Dispute Settles in 21 Days
Ouraring, Inc. brought an ITC Section 337 infringement action against RingConn LLC asserting US11868178B2, a patent covering wearable computing device technology. The dispute resolved by settlement just 21 days after filing — an unusually rapid conclusion for ITC proceedings, suggesting commercial negotiation may have been underway well before the complaint was filed.
Smart ring rivals resolve ITC clash before investigation gains traction
On 17 November 2025, Ouraring, Inc. initiated ITC Investigation No. 337-TA-1398 by filing a Section 337 complaint against RingConn LLC. The action centred on US11868178B2, a patent covering wearable computing device technology — the category that encompasses smart rings capable of biometric monitoring and health tracking. Ouraring and RingConn compete directly in the emerging consumer smart ring market, where Oura Ring holds significant brand recognition and RingConn has emerged as a lower-cost challenger.
The case was terminated on 8 December 2025 on the basis that the parties had reached a settlement, just 21 days after the complaint was filed. The ITC issued no Section 337 violation finding, no exclusion order, and no cease-and-desist order against RingConn. Settlement at this stage means the investigation was likely terminated before the ITC formally instituted the investigation or shortly thereafter, with no substantive merits adjudication on the record.
A 21-day resolution is notably swift even by settlement standards at the ITC, where most cases that settle do so after institution. This timeline suggests the parties may have been in advanced commercial discussions before or contemporaneously with filing, potentially using the complaint as leverage. The precise settlement terms — licensing arrangement, design-around commitments, or financial consideration — are not publicly disclosed, leaving the ultimate commercial outcome between the parties opaque.
Filing to Case Settled in 21 days
21 days — resolved well before the typical ITC 15–18 month investigation cycle.
Case settled: what the rapid ITC resolution means for both parties
Section 337 settled before any violation ruling
An ITC Section 337 investigation is terminated by settlement when both parties notify the Commission they have resolved their dispute. Crucially, settlement produces no finding of violation, no exclusion order barring RingConn products at the US border, and no cease-and-desist order. The case ends procedurally without establishing any public precedent on the validity or infringement of US11868178B2.
No merits adjudicationOuraring avoids a lengthy investigation — at a strategic cost
Settlement preserves Ouraring’s patent without subjecting US11868178B2 to an ITC invalidity analysis that could weaken it. However, because no exclusion order was issued, Ouraring gains no import ban against RingConn. Whether it secured licensing revenue, design-around commitments, or market-entry restrictions from RingConn is unknown from the public record. The filing itself may have served as a credible deterrent signal to other smart ring entrants.
Patent intact; no exclusion orderRingConn avoids an exclusion order but settlement terms are unknown
RingConn avoids the most commercially damaging ITC outcome — a general exclusion order that could have barred its products from US importation entirely. Settlement at pre-institution stage also avoids the reputational and operational disruption of a full ITC investigation. Whether RingConn made financial or product concessions to reach settlement is not disclosed. It may continue US market activities, though potentially subject to undisclosed licensing or design constraints.
No import ban imposedITC filings are an effective negotiating lever in the smart ring market
This outcome is consistent with a pattern where ITC complaints function as high-pressure negotiating tools rather than pure litigation vehicles. The wearable computing device market — particularly smart rings — is attracting multiple competitors challenging Oura’s incumbency. A rapid settlement here suggests established players may continue using ITC filings tactically to manage competitive entry, with US border exclusion risk concentrating defendants’ minds quickly.
ITC as competitive leverageFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Ouraring, Inc. | Company | Wearable health technology company — holder of US11868178B2, wearable computing device IPSearch in Eureka ↗ |
| Defendant | RingConn LLC | Company | RingConn LLC — consumer smart ring manufacturer and competitor to Ouraring in the wearable marketSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | United States of ITCSearch in Eureka ↗ |
Official order — verbatim text
The recorded disposition — ‘Settlement’ with basis of termination ‘Case Settled’ — reflects a consensual resolution before any ITC Commissioner ruling on the merits. No Section 337 violation, exclusion order, or cease-and-desist order was issued. This phrasing confirms the investigation ended purely on procedural and commercial grounds. Neither infringement of US11868178B2 nor its validity was adjudicated, meaning the patent’s enforceability and claim scope remain open questions for subsequent proceedings or licensing negotiations.
US11868178B2 — Wearable computing device technology for smart rings
US11868178B2, filed under application number US18/323385, protects wearable computing device technology in the smart ring category. This patent family sits at the intersection of miniaturised hardware design, biometric sensing, and embedded data processing — the core engineering challenge in ring-form-factor wearables. The patent’s issuance as a B2 grant indicates it has cleared examination, though its claim scope has not been tested in adversarial post-grant proceedings or trial.
For the wearable health technology sector, US11868178B2 represents a potentially significant barrier to market entry in the US. As smart rings move from niche to mainstream — driven by consumer demand for discreet, continuous health monitoring — patents covering device architecture and computation methods carry growing commercial weight. Ouraring’s willingness to assert this patent at the ITC signals it views the claim scope as commercially meaningful. Any competitor shipping ring-form-factor wearables to the US should treat this patent as a live enforcement risk.
Should you run an FTO against US11868178B2 before entering the smart ring market?
Any company designing, importing, or distributing wearable ring-form-factor devices for the US market — particularly products incorporating biometric sensors, motion tracking, or onboard data processing — should conduct a freedom-to-operate analysis against US11868178B2 and related Ouraring continuations. The ITC’s jurisdiction over imported goods means exposure is not limited to US-manufactured products; overseas manufacturers shipping to US retailers face the same Section 337 risk that RingConn faced.
PatSnap Eureka’s FTO Search Agent can map the claim landscape of US11868178B2 against your product’s technical architecture, identify relevant prior art that may constrain claim scope, surface related patents in the Ouraring portfolio, and flag design-around pathways. Given that this patent’s validity and infringement scope remain untested by any tribunal, a structured FTO is the most reliable way to quantify your risk before committing to US market entry or manufacturing tooling.
Run a freedom-to-operate analysis on US11868178B2 to assess your product’s exposure
Run FTO in Eureka →Similar ITC Section 337 cases involving wearable device patents
Explore other ITC investigations asserting wearable computing device and health monitoring patents before the United States International Trade Commission.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable Wearable computing device-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedOuraring, Inc.’s broader IP enforcement history
Ouraring, Inc.’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the wearable smart ring IP landscape
A 21-day ITC settlement in the smart ring space carries implications beyond these two parties — it signals how IP enforcement will shape this market.
Smart ring incumbents are willing to use ITC proceedings aggressively
Ouraring’s rapid filing and equally rapid settlement suggests the ITC is now a standard tool in the smart ring IP arsenal. Companies entering the US wearable market with products overlapping Ouraring’s patent portfolio should anticipate Section 337 risk as part of their market entry calculus, not merely district court litigation.
US11868178B2 remains untested — its claim scope is still live risk
Because the ITC issued no invalidity or non-infringement ruling, US11868178B2 exits this proceeding with its presumption of validity fully intact. Competitors in the wearable computing device space cannot rely on this case to establish a safe harbour. An FTO analysis against this patent remains essential for any company shipping smart ring products to the US market.
Pre-institution settlement suggests licensing terms were pre-negotiated
Settling in 21 days — before the ITC typically even institutes an investigation — strongly suggests back-channel licensing or commercial discussions predated the complaint. Monitoring Ouraring’s licensing activity and any follow-on ITC or district court filings could reveal the contours of an emerging licensing programme targeting smart ring competitors.
Wearable sensor IP is consolidating around a small set of key patents
US11868178B2 and related continuations in the wearable computing device family represent a meaningful IP barrier to entry. Companies developing optical biosensing, motion detection, or data processing features in ring-form-factor devices should map their product architecture against Ouraring’s full patent portfolio — not just the asserted patent — to identify design-around opportunities before US launch.
Ouraring v RingConn — key questions answered
Ouraring, Inc. filed a Section 337 complaint against RingConn LLC on 17 November 2025 asserting US11868178B2, a wearable computing device patent. The case settled just 21 days later on 8 December 2025. No ITC violation finding, exclusion order, or cease-and-desist order was issued. Settlement terms are not publicly disclosed.
US11868178B2 is a granted US patent filed under application US18/323385 that covers wearable computing device technology, relevant to smart ring products. The patent sits in the domain of miniaturised wearable hardware and embedded processing. Its precise claim scope has not been adjudicated by a tribunal, as the ITC case settled before any merits ruling.
The 21-day resolution is consistent with a scenario where commercial negotiations were already advanced before the complaint was filed, with the ITC filing serving as leverage to accelerate settlement. Pre-institution ITC settlements are not uncommon when defendants face the credible risk of a border exclusion order. The precise commercial terms driving the rapid resolution are not public.
No exclusion order was issued by the ITC, so there is no public legal bar preventing RingConn from importing or selling its products in the US market. However, the settlement may include undisclosed licensing conditions, design-around obligations, or other commercial constraints. Without access to the settlement agreement, the full scope of RingConn’s ongoing US market rights cannot be confirmed from the public record.
Because the ITC issued no invalidity or non-infringement finding, US11868178B2 exits this proceeding with its presumption of validity fully intact. Other smart ring manufacturers importing products into the US cannot rely on this settlement as a safe harbour. A freedom-to-operate analysis against this patent and related Ouraring continuations is advisable for any company developing wearable ring-form-factor devices for the US market.
Map your smart ring IP risk before the next ITC complaint lands
With US11868178B2 untested on the merits and Ouraring demonstrating ITC enforcement readiness, FTO analysis is essential for any wearable ring-form-factor product targeting the US market. PatSnap Eureka helps you identify claim exposure and design-around options before launch.
PatSnap Eureka searches patents and litigation data to answer instantly.